| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |